Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05819827
What this trial is testing

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Who this might be right for
Bladder CancerProstate CancerTesticular Cancer+6 more
Mayo Clinic 13
Testing effectiveness (Phase 2)Study completedNCT04123470
What this trial is testing

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Who this might be right for
Malignant Melanoma
Lokon Pharma AB 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05089370
What this trial is testing

Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

Who this might be right for
Malignant Melanoma
University of Colorado, Denver 8
Not applicableStudy completedNCT03898687
What this trial is testing

The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.

Who this might be right for
MelanomaSentinel Lymph Node
Sahlgrenska University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00004104
What this trial is testing

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07215182
What this trial is testing

[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Who this might be right for
Malignant Melanoma Stage IV
Barbara Malene Fischer 20
Early research (Phase 1)Ended earlyNCT06270082
What this trial is testing

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Cancer+7 more
Ikena Oncology 75
Testing effectiveness (Phase 2)Study completedNCT00044356
What this trial is testing

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaMalignant Melanoma+1 more
Vical 133
Testing effectiveness (Phase 2)UnknownNCT04879654
What this trial is testing

Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

Who this might be right for
Malignant MelanomaSinonasal Melanoma
Eye & ENT Hospital of Fudan University 45
Not applicableStudy completedNCT02373722
What this trial is testing

Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery

Who this might be right for
Malignant Skin Neoplasm
Wake Forest University Health Sciences 90
Testing effectiveness (Phase 2)Study completedNCT01227551
What this trial is testing

Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Who this might be right for
Malignant Melanoma
Viralytics 57
Large-scale testing (Phase 3)Study completedNCT00864253
What this trial is testing

A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Celgene 529
Early research (Phase 1)Study completedNCT00002754
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
Duke University 6
Early research (Phase 1)Study completedNCT05538572
What this trial is testing

PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerGlioblastomaHead and Neck Squamous Cell Carcinoma+4 more
Prelude Therapeutics Incorporated 22
Testing effectiveness (Phase 2)UnknownNCT02501551
What this trial is testing

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Who this might be right for
Melanoma
Yonsei University 36
Not applicableLooking for participantsNCT04693377
What this trial is testing

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the Bone+15 more
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT01014819
What this trial is testing

A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

Who this might be right for
Basal Cell Carcinoma
UCSF Benioff Children's Hospital Oakland 30
Not applicableNo Longer AvailableNCT03424473
What this trial is testing

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.
Not applicableUnknownNCT04747561
What this trial is testing

Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma

Who this might be right for
Melanoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)Study completedNCT01386580
What this trial is testing

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

Who this might be right for
Brain MetastasesLung CancerBreast Cancer+2 more
BBB-Therapeutics B.V. 84
Next Page